BLTE Belite Bio
- 37.270
- +0.270+0.73%
Belite Bio News
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 20-F: Registration statement / Annual report / Transition report
Belite Bio | 6-K: Report of foreign private issuer (related to financial reporting)
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yu-Hsin Lin(7.3%)
Belite Bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lin Bioscience International Ltd.(58.6%)
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 6-K: Report of foreign private issuer (related to financial reporting)
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Belite Bio | 6-K: Report of foreign private issuer (related to financial reporting)
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
